{"id":397745,"date":"2020-12-10T16:04:14","date_gmt":"2020-12-10T21:04:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=397745"},"modified":"2020-12-10T16:04:14","modified_gmt":"2020-12-10T21:04:14","slug":"micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","title":{"rendered":"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BOCA RATON, Fla., Dec.  10, 2020  (GLOBE NEWSWIRE) &#8212; Micron Medical (\u201cMicron\u201d or \u201cthe Company\u201d), a privately-held, commercial stage medical device company preparing to launch a revolutionary minimally invasive neurostimulator for treating patients suffering with an overactive bladder (OAB), today announced that it will be presenting at the 13<sup>th<\/sup> Annual LD Micro Main Event virtual investor conference on Monday, December 14, at 3:00 PM EST \/ 12:00 PM PST.<\/p>\n<p align=\"justify\">Micron\u2019s lead product, Protect PNS, is a revolutionary minimally invasive neurostimulator for treating OAB, a debilitating condition that affects more than 37 million people in the U.S., with 7 million patients seeking medical treatment each year. Micron has submitted a De Novo 510(k) application for PROTECT PNS and, pending receipt of FDA classification, the product is expected to be commercially available in the U.S. in 2021.<\/p>\n<p align=\"justify\">Mark Landy, Micron\u2019s Chief Executive Officer, will be presenting to a live, virtual audience.<\/p>\n<p align=\"justify\">Interested participants can register to view the presentation and Q&amp;A session at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3U7MePQOG0NICAFiURNYVQb4SdAzfORsXiJdGx5nqULdrJ-MaBxxlz8R2x7z6dI-dzUMTKL_GghUZD0GPU9qCgEi2qwDxfan9ZRj2jryNLX8ZJaUKIBQUyCeBCEOGWF1mXsFH6AURlrH6OVCAOS1BDLFt85IKIEVsnbLdpXl59GA0RMdbTenkE34BrBh1M9JDlylxZTislV2oVxKbg72gFoiYxUeOCdh8swZM1obkao=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>ve.mysequire.com\/<\/strong><\/a><\/p>\n<p align=\"justify\">To view a replay of \u201cMicron Medical\u2019s KOL Webinar on Protect PNS for OAB: A Percutaneous Wireless Micro-Neurostimulation Technology featuring Dr. Larry Sirls and Dr. Ken Peters from Beaumont Health\u201d, please visit the following:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qjyRkTWXFy45WSn_6APvGvrtcl4rHlnGn7JXx17h3hlviju56UPRZ5ujQD9XHd6tPUciNKaNkiTqsv-mrt8nnOftDFElvuzPwVepsWC2piByrdzjLw6w2pUzrHrugIzf6dGErCzIk23oPwSr8DSFQv7L2clRmm2q2RxeUCbanmU98oi3n8H1mqztM78SHcXf9cDLGnm-zcgNSeKMxWSxRBCCZSBGdIVjSIEfqKsCRGTXmw-cmRTugAIwQcRruyM94LYuXFClc_3hYmIVdFgIoDP3GsK_58uQO5AhGGympaAbQjAfWK51SftaNHjfVL1oRrDDsXzFGhqqtWSsqe7iJzCQVEzLgnPyTZEVWF2rCeWsYlXk3390mGvbyGIqwdr6hqZD6MnB0XHuqhTm5KKdc_emo4y-xp2n0GS_2vvQLdjh1qtHFGiv9EyysoGZvhcqG8uV3IS810Yf_3IsR6fNXBwPTUGG8FNsAuy3ZKDcxxIFEpSv1uEk8jS6SdYQwxEc\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>https:\/\/lifescipartners.zoom.us\/rec\/play\/vqQgr63TEBxT_VmQKRfaZhsQtMtNt2TA5Ou4IB41Ap_DfxjrGJXlksgb4CCLpFGaUYmuz9CLJ4voXXL6.RpEI0llKoUqrzhad?autoplay=true&amp;startTime=1607529758000<\/strong><\/a><\/p>\n<p align=\"justify\">\n        <strong>About Micron Medical<\/strong>\n      <\/p>\n<p align=\"justify\">Micron Medical is a privately-held, commercial stage medical device company focused on the development, manufacturing, and marketing of wirelessly powered, microtechnology neurostimulators, providing patients with convenient, safe, minimally invasive, and highly cost-effective urological solutions. The Company\u2019s lead product, Protect PNS, is a revolutionary minimally invasive neurostimulator for treating overactive bladder, which is a multi-billion dollar market with a significant unmet need in which patients have a substantially impacted quality of life. A De Novo 510(k) for Protect PNS has been submitted to the U.S. Food and Drug Administration (FDA) and, pending receipt of FDA classification, the product is expected to be commercially available in the U.S. in 2021, with a Category III reimbursement code already established. Micron\u2019s goal is to evolve its patented, cutting-edge platform for neuromodulation to standard of care, increasing the accessibility for patients worldwide, while lowering the economic impact of urology care management. Further information is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PR34pNlrhJpNuE-6R-7z2nQutR03tpWtnUIMvn5AOGNCsjZwJO29sQGGn6XMh3sd2NagN3Fs3VBfwbWiAtMpHQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.micronmed.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Contacts<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Gil Bao<br \/>Micron Medical Corporation<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3T3X1PLfUhoDdeNBkPOXWXFGnQNDslLeOmUBF_NwZ44AzZANu4xyfMibKq1BC24rzVJDokpY1X7CgS_bJxg6rnDwwTbnh6Z-EEGGeH44Vv4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@micronmed.com<\/a><br \/>888.691.0585<\/p>\n<p align=\"justify\">Jeremy Feffer<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hD8ivEF8sIeCweLsUZIXvCw0hqUyv_pmfJAOx7yrQhKWVdAYmPnbqg8bFxnC-7hg7dj_JkWF4iPa4vfvLAP72m4NuI3qzjXNamOyeZuE2QTI7KeqTPYX70_vakCoFId_\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jeremy@lifesciadvisors.com<\/a><br \/>212.915.2568<\/p>\n<p align=\"justify\">\n        <em>Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company\u2019s products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.<\/em>\n      <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/a6d6d9d6-f21d-4a1b-84ea-b58e597ec862\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOCA RATON, Fla., Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; Micron Medical (\u201cMicron\u201d or \u201cthe Company\u201d), a privately-held, commercial stage medical device company preparing to launch a revolutionary minimally invasive neurostimulator for treating patients suffering with an overactive bladder (OAB), today announced that it will be presenting at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14, at 3:00 PM EST \/ 12:00 PM PST. Micron\u2019s lead product, Protect PNS, is a revolutionary minimally invasive neurostimulator for treating OAB, a debilitating condition that affects more than 37 million people in the U.S., with 7 million patients seeking medical treatment each year. Micron has submitted a De Novo 510(k) application for PROTECT PNS and, pending receipt of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-397745","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOCA RATON, Fla., Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; Micron Medical (\u201cMicron\u201d or \u201cthe Company\u201d), a privately-held, commercial stage medical device company preparing to launch a revolutionary minimally invasive neurostimulator for treating patients suffering with an overactive bladder (OAB), today announced that it will be presenting at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14, at 3:00 PM EST \/ 12:00 PM PST. Micron\u2019s lead product, Protect PNS, is a revolutionary minimally invasive neurostimulator for treating OAB, a debilitating condition that affects more than 37 million people in the U.S., with 7 million patients seeking medical treatment each year. Micron has submitted a De Novo 510(k) application for PROTECT PNS and, pending receipt of &hellip; Continue reading &quot;Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-10T21:04:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference\",\"datePublished\":\"2020-12-10T21:04:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\"},\"wordCount\":500,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\",\"name\":\"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==\",\"datePublished\":\"2020-12-10T21:04:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk","og_description":"BOCA RATON, Fla., Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; Micron Medical (\u201cMicron\u201d or \u201cthe Company\u201d), a privately-held, commercial stage medical device company preparing to launch a revolutionary minimally invasive neurostimulator for treating patients suffering with an overactive bladder (OAB), today announced that it will be presenting at the 13th Annual LD Micro Main Event virtual investor conference on Monday, December 14, at 3:00 PM EST \/ 12:00 PM PST. Micron\u2019s lead product, Protect PNS, is a revolutionary minimally invasive neurostimulator for treating OAB, a debilitating condition that affects more than 37 million people in the U.S., with 7 million patients seeking medical treatment each year. Micron has submitted a De Novo 510(k) application for PROTECT PNS and, pending receipt of &hellip; Continue reading \"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-10T21:04:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference","datePublished":"2020-12-10T21:04:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/"},"wordCount":500,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/","name":"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==","datePublished":"2020-12-10T21:04:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDM2NyMzODY2Mzk1IzUwMDA3MDg0NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/micron-medical-to-present-at-the-13th-annual-ld-micro-main-event-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Micron Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=397745"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/397745\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=397745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=397745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=397745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}